Table 3.

Correlations between clinicopathological parameters and tumor response to neoadjuvant treatment

Clinicopathological Parameters	Good response
High vs. Low CD3+TILs	55.4% vs. 37.1%; P = 0.033*
High vs. Low CD8+TILs	56% vs. 36.1%; P = 0.021*
Age < 65 vs. age ≥ 65	45.3% vs. 48.6%; P = 0.700
Male vs. Female gender	46.6% vs. 47.5%; P = 0.919
Differentiated vs. Undifferentiated history	53.4% vs. 42.3%; P = 0.198
cT3 vs. cT4 stage	54.6% vs. 37.7%; P = 0.049*
Node negative vs. Node positive	65.9% vs. 38.0%; P = 0.002*

^*Statistically significant.